当前位置:首页 - 行情中心 - 派林生物(000403) - 财务分析 - 现金流量表

派林生物

(000403)

  

流通市值:110.15亿  总市值:111.29亿
流通股本:9.41亿   总股本:9.50亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金474,645,161.972,126,498,241.351,638,382,857.13968,008,291.47
  收到的税费返还-5,367,630.65-5,367,630.65
  收到其他与经营活动有关的现金5,452,119.6633,882,533.9637,527,087.5813,061,201.64
  经营活动现金流入小计480,097,281.632,165,748,405.961,675,909,944.71986,437,123.76
  购买商品、接受劳务支付的现金374,194,999.431,439,516,459.31,078,534,154.42714,626,626.57
  支付给职工以及为职工支付的现金113,372,082.92354,237,291.72274,556,311.9195,007,275.3
  支付的各项税费86,816,287.42223,234,516.9165,157,908.47112,024,277
  支付其他与经营活动有关的现金77,565,467364,750,751.3254,148,415.01157,442,842.68
  经营活动现金流出小计651,948,836.772,381,739,019.221,772,396,789.81,179,101,021.55
  经营活动产生的现金流量净额-171,851,555.14-215,990,613.26-96,486,845.09-192,663,897.79
二、投资活动产生的现金流量:
  收回投资收到的现金300,000,0001,480,000,000880,000,000660,000,000
  取得投资收益收到的现金2,723,573.6117,593,226.8614,126,885.6313,099,369.04
  处置固定资产、无形资产和其他长期资产收回的现金净额1,911.5493,018.55211,783.8195,791.18
  收到的其他与投资活动有关的现金13,315,068.4953,999,999.9840,536,986.2926,926,027.39
  投资活动现金流入小计316,040,553.61,552,086,245.39934,875,655.73700,121,187.61
  购建固定资产、无形资产和其他长期资产支付的现金33,776,304.86333,403,421.77250,229,572.61178,057,408.07
  投资支付的现金310,000,0001,450,000,0001,260,050,000860,000,000
  支付其他与投资活动有关的现金100,000,000---
  投资活动现金流出小计443,776,304.861,783,403,421.771,510,279,572.611,038,057,408.07
  投资活动产生的现金流量净额-127,735,751.26-231,317,176.38-575,403,916.88-337,936,220.46
三、筹资活动产生的现金流量:
  吸收投资收到的现金-100,00050,000-
  其中:子公司吸收少数股东投资收到的现金-100,00050,000-
  取得借款收到的现金103,500,000771,207,747.13534,318,741.72258,151,722.36
  筹资活动现金流入小计103,500,000771,307,747.13534,368,741.72258,151,722.36
  偿还债务支付的现金133,133,164.62595,309,148.65337,713,522.4225,020,253.08
  分配股利、利润或偿付利息支付的现金4,858,839.98273,799,760.63268,908,749.44263,568,181.66
  支付其他与筹资活动有关的现金517,811.015,704,350.383,375,393.333,159,348.07
  筹资活动现金流出小计138,509,815.61874,813,259.66609,997,665.17491,747,782.81
  筹资活动产生的现金流量净额-35,009,815.61-103,505,512.53-75,628,923.45-233,596,060.45
四、汇率变动对现金及现金等价物的影响-31,771.3849,364.89-23,583.88-8,285.78
五、现金及现金等价物净增加额-334,628,893.39-550,763,937.28-747,543,269.3-764,204,464.48
  加:期初现金及现金等价物余额769,596,617.331,320,360,554.611,320,360,554.611,320,360,554.61
  期末现金及现金等价物余额434,967,723.94769,596,617.33572,817,285.31556,156,090.13
补充资料:
  净利润-419,535,951.9-235,916,844.55
  资产减值准备-100,052,963.37-1,224,723.08
  固定资产和投资性房地产折旧-116,414,975.28-53,503,913.82
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-116,386,495.44-53,503,913.82
    投资性房地产折旧-28,479.84--
  无形资产摊销-20,591,534.24-10,167,262.6
  长期待摊费用摊销-9,271,024.41-4,631,699.48
  处置固定资产、无形资产和其他长期资产的损失--756,002.27--785,805.25
  固定资产报废损失-754,255.1-454,300.7
  公允价值变动损失--4,296,114.07-6,227,157.72
  财务费用--32,814,439.01--18,086,692.72
  投资损失--8,953,532.37--13,721,248.52
  递延所得税-2,593,122.97--813,919.75
  其中:递延所得税资产减少-2,843,705.76-89,177.45
    递延所得税负债增加--250,582.79--903,097.2
  存货的减少--332,406,933.51--368,094,721.19
  经营性应收项目的减少--472,671,425.47-63,188,902.22
  经营性应付项目的增加--47,788,798.62--168,372,435.6
  现金的期末余额-769,596,617.33-556,156,090.13
  减:现金的期初余额-1,320,360,554.61-1,320,360,554.61
  现金及现金等价物的净增加额--550,763,937.28--764,204,464.48
公告日期2026-04-292026-04-292025-10-292025-08-22
审计意见(境内)标准无保留意见
TOP↑